Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.61 |
| ▸ | HTT | P42858 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | MMP13 | P45452 | 3/20 | 0.55 |
| ▸ | PLK1 | P53350 | 3/20 | 0.47 |
| ▸ | S1PR2 | O95136 | 6/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.44 |
| ▸ | MMP2 | P08253 | 1/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.43 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.43 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.40 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.40 |
| ▸ | MMP3 | P08254 | 1/20 | 0.40 |
| ▸ | MMP10 | P09238 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21628505 | 0.89 | HPGD (0.58) | HPGDTSHRHTTSMN1; SMN2MMP13 | |
| SCHEMBL21628875 | 0.87 | ALOX15 (0.45) | HPGDTSHRHTTSMN1; SMN2MMP13 | |
| SCHEMBL21628581 | 0.85 | SLC6A2 (0.47) | HPGDTSHRHTTSMN1; SMN2MMP13 | |
| SCHEMBL21656672 | 0.85 | SLC6A2 (0.47) | HPGDTSHRHTTSMN1; SMN2MMP13 | |
| SCHEMBL21628674 | 0.85 | SLC6A2 (0.50) | HPGDTSHRHTTSMN1; SMN2MMP13 | |
| SCHEMBL21656808 | 0.85 | OPRM1 (0.49) | HPGDTSHRHTTSMN1; SMN2HRH3 | |
| SCHEMBL20482655 | 0.84 | CA1 (0.47) | HPGDTSHRHTTSMN1; SMN2MMP13 | |
| SCHEMBL21656966 | 0.84 | SLC6A2 (0.47) | HPGDTSHRHTTSMN1; SMN2MMP13 | |
| SCHEMBL20482167 | 0.82 | RXRA (0.49) | TSHRMMP13S1PR2MMP2EPHX2 | |
| SCHEMBL21628479 | 0.81 | PARP10 (0.58) | MMP13S1PR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230406814-A2 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2023-12-21 | — | — | US | disclosed |
| US-20230150923-A1 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2023-05-18 | — | — | US | disclosed |
| US-11591289-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2023-02-28 | — | — | US | disclosed |
| US-11591289-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2023-02-28 | — | — | US | disclosed |
| US-20210107863-A2 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2021-04-15 | — | — | US | disclosed |
| US-20200031763-A1 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2020-01-30 | — | — | US | disclosed |
| US-20200031763-A1 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2020-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230150923-A1 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | HPGD 2579/4885TSHR 3747/4885HTT 550/4885 |
| US-11591289-B2 | Aromatic compounds | AHR, TYR, MUSK | HPGD 2313/4885TSHR 3622/4885HTT 304/4885 |
| US-20210107863-A2 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | HPGD 2579/4885TSHR 3747/4885HTT 550/4885 |
| US-20230406814-A2 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | HPGD 2579/4885TSHR 3747/4885HTT 550/4885 |
| US-20200031763-A1 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | HPGD 2579/4885TSHR 3747/4885HTT 550/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.